Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin
Sonia Gioffré, Mattia Chiesa, Daniela Cardinale, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1418-1418
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4229-4361
Open Access | Times Cited: 1595
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal - Cardiovascular Imaging (2022) Vol. 23, Iss. 10, pp. e333-e465
Open Access | Times Cited: 216
Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity
Hanne M. Boen, Martina Cherubin, Constantijn Franssen, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 183-199
Open Access | Times Cited: 9
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Carlo G. Tocchetti, Pietro Ameri, Rudolf A. de Boer, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 11, pp. 1820-1834
Open Access | Times Cited: 69
Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis
Fahimeh Varzideh, Urna Kansakar, Kwame Donkor, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 38
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 18
A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research
Cameron Brown, Michael D. Mantzaris, Elpiniki Nicolaou, et al.
Cardio-Oncology (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 21
microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis
Jéssica Diniz Pereira, Jéssica Abdo Gonçalves Tosatti, Ricardo Simões, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110709-110709
Open Access | Times Cited: 32
CHEMOTHERAPY-INDUCED CARDIAC TOXICITY AND HEART FAILURE
S. R. Bayramzade, N. I. Mehdiyeva, Bakhshiyev Mm
World of Medicine and Biology (2025) Vol. 20, Iss. 90, pp. 229-229
Closed Access
Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials
Mei Zhao, Xiaohong Zhang, Dongyang Zhou, et al.
Open Access Journal of Clinical Trials (2025) Vol. Volume 17, pp. 1-14
Open Access
MicroRNA-1: Diverse role of a small player in multiple cancers
Parvez Κhan, Nivetha Sarah Ebenezer, Jawed A. Siddiqui, et al.
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 114-126
Open Access | Times Cited: 23
Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development
Abhijit Pal, Rajiv Shinde, Manuel Selvi Miralles, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 7, pp. 454-467
Closed Access | Times Cited: 19
MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats
Rafael Sánchez-Sánchez, Ignacio Reinal, Esteban Peiró-Molina, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1955-1955
Open Access | Times Cited: 13
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3290-3290
Open Access | Times Cited: 8
Early detection of anthracycline-induced cardiotoxicity
Weimin Feng, Qingchen Wang, Yuan Tan, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 120000-120000
Open Access | Times Cited: 2
MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
Varsha G. Desai, Vikrant Vijay, Taewon Lee, et al.
Journal of Applied Toxicology (2022) Vol. 42, Iss. 9, pp. 1477-1490
Closed Access | Times Cited: 10
Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction
Claire Tonry, Adam Russell‐Hallinan, Claire McCune, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 710-728
Open Access | Times Cited: 9
Comprehensive analysis of the role of SFXN family in breast cancer
Yuan Ding, Jialiang Liu, Wenbo Sang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction—Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage
Milijana Janjusevic, Alessandra Lucia Fluca, Federico Ferro, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4937-4937
Open Access | Times Cited: 12
microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation
Michelle Teodoro Alves, Izabela Mamede, Angélica Navarro de Oliveira, et al.
Cardiovascular Toxicology (2022) Vol. 22, Iss. 7, pp. 655-662
Closed Access | Times Cited: 7
The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
Zihan Si, Yan Zhong, Sixian Lao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
Liuying Chen, Yizhou Xu
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 9
Biomarker Determinants of Early Anthracycline-Induced Left Ventricular Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis
Stavroula Kastora, Tiberiu A. Pana, Yusuf Sarwar, et al.
Molecular Diagnosis & Therapy (2022) Vol. 26, Iss. 4, pp. 369-382
Closed Access | Times Cited: 6
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review
Roberto Rosenfeld, Silvia Riondino, Vincenzo Formica, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1059-1059
Open Access | Times Cited: 6
Cardio-Oncology in Childhood: State of the Art
Elena Bennati, Francesca Girolami, Gaia Spaziani, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 12, pp. 1765-1777
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top